RAC 0.60% $1.69 race oncology ltd

Ann: June 2018 Quarterly Report, page-18

  1. 711 Posts.
    lightbulb Created with Sketch. 661

    Last thing I will say on this topic. If this was 100% chance of success we would be $500m+ market cap ($6.50 per share) rather than $10m, for a phase 3 ready asset that has tested well against current "promising" treatments including Venetoclax.Like all bios, RAC is not without some risk, but the preliminary data is highly promising and as such RAC is de-risked well beyond the market value here. 


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.